Overview
Basic information about this protein and its source genome.
- Accession
- KP13_31619
- Gene
- AHE42459.1 gltB
- Status
- annotated
- Amino acids
- 1486
- Structure source
- AlphaFold + ColabFold
Target profile
Computed evidence for target prioritization.
- Human off-target
- No hit
- Human identity (%)
- 0.0
- Gut microbiome off-target
- hit
- Essential (DEG)
- Y
- DEG identity (%)
- 59.458
- DEG E-value
- 0.0
- Localization
- Cytoplasmic
- ColabFold pLDDT
- 94.27
Selected Druggability evidence
AlphaFold / UniProt modelSelected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
Functional Annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Enzyme Commission (EC)
1Gene Ontology (GO)
9- GO:0006537 OBSOLETE. The chemical reactions and pathways resulting in the formation of glutamate, the anion of 2-aminopentanedioic acid.
- GO:0016638 Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH2 group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
- GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
- GO:0006807 OBSOLETE. The chemical reactions and pathways involving organic or inorganic compounds that contain nitrogen.
- GO:0015930 Catalysis of the formation of L-glutamine and 2-oxoglutarate from L-glutamate, using NADH, NADPH or ferredoxin as hydrogen acceptors.
- GO:0051538 Binding to a 3 iron, 4 sulfur (3Fe-4S) cluster; this cluster consists of three iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands. It is essentially a 4Fe-4S cluster with one iron missing.
- GO:0004355 Catalysis of the reaction: 2 L-glutamate + NADP+ = 2-oxoglutarate + L-glutamine + H+ + NADPH. This is a two-step reaction: (a) L-glutamate + NH4+ = L-glutamine + H2O, (b) L-glutamate + NADP+ + H2O = NH4+ + 2-oxoglutarate + NADPH + H+.
- GO:0046872 Binding to a metal ion.
- GO:0019676 The pathway by which ammonia is processed and incorporated into a cell. In an energy-rich (glucose-containing), nitrogen-poor environment, glutamine synthetase and glutamate synthase form an ammonia assimilatory cycle, in which ammonia is incorporated into L-glutamate to form L-glutamine, which then combines with alpha-ketoglutarate to regenerate L-glutamate. This ATP-dependent cycle is essential for nitrogen-limited growth and for steady-state growth with some sources of nitrogen.
Sequence Features
Domain/signature hits from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 1213 | 1463 | CDD | cd00982 | gltB_C |
| 1213 | 1463 | InterPro | IPR002489 | Glutamate synthase, alpha subunit, C-terminal |
| 482 | 1171 | Gene3D | G3DSA:3.20.20.70 | Aldolase class I |
| 482 | 1171 | InterPro | IPR013785 | Aldolase-type TIM barrel |
| 784 | 1195 | FunFam | G3DSA:3.20.20.70:FF:000061 | Glutamate synthase large subunit |
| 12 | 435 | FunFam | G3DSA:3.60.20.10:FF:000001 | Glutamate synthase, large subunit |
| 1199 | 1467 | FunFam | G3DSA:2.160.20.60:FF:000002 | Glutamate synthase, large subunit |
| 12 | 402 | ProSiteProfiles | PS51278 | Glutamine amidotransferase type 2 domain profile. |
| 12 | 402 | InterPro | IPR017932 | Glutamine amidotransferase type 2 domain |
| 436 | 783 | FunFam | G3DSA:3.20.20.70:FF:000109 | Glutamate synthase, large subunit |
| 429 | 785 | Gene3D | G3DSA:3.20.20.70 | Aldolase class I |
| 429 | 785 | InterPro | IPR013785 | Aldolase-type TIM barrel |
| 1211 | 1465 | SUPERFAMILY | SSF69336 | Alpha subunit of glutamate synthase, C-terminal domain |
| 1211 | 1465 | InterPro | IPR036485 | Glutamate synthase, alpha subunit, C-terminal domain superfamily |
| 1197 | 1467 | Gene3D | G3DSA:2.160.20.60 | - |
| 1197 | 1467 | InterPro | IPR036485 | Glutamate synthase, alpha subunit, C-terminal domain superfamily |
| 12 | 420 | CDD | cd00713 | GltS |
| 796 | 1170 | CDD | cd02808 | GltS_FMN |
| 796 | 1170 | InterPro | IPR002932 | Glutamate synthase domain |
| 15 | 1466 | PANTHER | PTHR11938 | FAD NADPH DEHYDROGENASE/OXIDOREDUCTASE |
| 793 | 1156 | Pfam | PF01645 | Conserved region in glutamate synthase |
| 793 | 1156 | InterPro | IPR002932 | Glutamate synthase domain |
| 12 | 544 | Gene3D | G3DSA:3.60.20.10 | Glutamine Phosphoribosylpyrophosphate, subunit 1, domain 1 |
| 12 | 544 | InterPro | IPR029055 | Nucleophile aminohydrolases, N-terminal |
| 1236 | 1418 | Pfam | PF01493 | GXGXG motif |
| 1236 | 1418 | InterPro | IPR002489 | Glutamate synthase, alpha subunit, C-terminal |
| 12 | 429 | SUPERFAMILY | SSF56235 | N-terminal nucleophile aminohydrolases (Ntn hydrolases) |
| 12 | 429 | InterPro | IPR029055 | Nucleophile aminohydrolases, N-terminal |
| 12 | 425 | Pfam | PF00310 | Glutamine amidotransferases class-II |
| 12 | 425 | InterPro | IPR017932 | Glutamine amidotransferase type 2 domain |
| 457 | 737 | Pfam | PF04898 | Glutamate synthase central domain |
| 457 | 737 | InterPro | IPR006982 | Glutamate synthase, central-N |
| 434 | 1191 | SUPERFAMILY | SSF51395 | FMN-linked oxidoreductases |
3D Structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.
Loading 3D structure...
Structural evidence
0 + 2Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold
AF_A0A0H3GY60
|
AlphaFold | — | — | full sequence | — | Viewing |
|
ColabFold
KP13_31619
|
ColabFold | — | — | full sequence | — | Loaded |
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 1 | 0.868 | ||||||
| 4 | 0.711 |
Pockets (P2RANK)
Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).
| P2RANK | Sticks | Spheres | Surfaces | Score | Probability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|---|
| 1 | 26.42 | 0.913 | ||||||
| 2 | 8.91 | 0.477 | ||||||
| 3 | 8.17 | 0.435 | ||||||
| 4 | 8.09 | 0.431 | ||||||
| 5 | 6.91 | 0.356 |
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 4 | 0.739 | ||||||
| 10 | 0.684 | ||||||
| 1 | 0.383 | ||||||
| 2 | 0.34 |
Pockets (P2RANK)
Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).
| P2RANK | Sticks | Spheres | Surfaces | Score | Probability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|---|
| 1 | 22.2 | 0.878 | ||||||
| 2 | 11.2 | 0.6 | ||||||
| 3 | 7.95 | 0.422 | ||||||
| 4 | 7.28 | 0.38 | ||||||
| 5 | 6.1 | 0.302 |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| AKG | P55038 | 146.1 Da LogP -0.50 TPSA 91.7 | ✓ Ro5 | ✓ Clean |
C(CC(=O)O)C(=O)C(=O)O
|
|
| F3S | P55038 | 295.8 Da LogP 2.59 TPSA 0.0 | ✓ Ro5 | ✓ Clean |
S1[Fe]2S[Fe]3[S]2[Fe]1S3
|
|
| OMT | Q05755 | 181.2 Da LogP -1.17 TPSA 97.5 | ✓ Ro5 | ✓ Clean |
CS(=O)(=O)CC[C@@H](C(=O)O)N
|
|
| ONL | P55038 | 145.2 Da LogP -0.23 TPSA 80.4 | ✓ Ro5 | ✓ Clean |
CC(=O)CC[C@@H](C(=O)O)N
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
| Ligand | Tanimoto | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|
| ZINC19429847 | 0.607 | 208.3 Da LogP -1.16 TPSA 80.5 | ✓ Ro5 | ✓ Clean |
CN(C)C(=O)[C@@H](N)CCS(C)(=O)=O
|
| ZINC19429848 | 0.607 | 208.3 Da LogP -1.16 TPSA 80.5 | ✓ Ro5 | ✓ Clean |
CN(C)C(=O)[C@H](N)CCS(C)(=O)=O
|
| ZINC26513844 | 0.607 | 209.3 Da LogP -0.69 TPSA 86.5 | ✓ Ro5 | ✓ Clean |
CCOC(=O)[C@@H](N)CCS(C)(=O)=O
|
| ZINC26513846 | 0.607 | 209.3 Da LogP -0.69 TPSA 86.5 | ✓ Ro5 | ✓ Clean |
CCOC(=O)[C@H](N)CCS(C)(=O)=O
|
| ZINC3055005 | 0.565 | 204.2 Da LogP -0.63 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@@H](CCCC[C@H](N)C(=O)O)C(=O)O
|
| ZINC3055007 | 0.565 | 204.2 Da LogP -0.63 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@@H](CCCC[C@@H](N)C(=O)O)C(=O)O
|
| ZINC3055010 | 0.565 | 204.2 Da LogP -0.63 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@H](CCCC[C@@H](N)C(=O)O)C(=O)O
|
| ZINC1555366 | 0.542 | 232.3 Da LogP 0.15 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@@H](CCCCCC[C@H](N)C(=O)O)C(=O)O
|
| ZINC1555367 | 0.542 | 232.3 Da LogP 0.15 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@@H](CCCCCC[C@@H](N)C(=O)O)C(=O)O
|
| ZINC1555369 | 0.542 | 232.3 Da LogP 0.15 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@H](CCCCCC[C@@H](N)C(=O)O)C(=O)O
|
| ZINC1720127 | 0.542 | 218.3 Da LogP -0.24 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@@H](CCCCC[C@H](N)C(=O)O)C(=O)O
|
| ZINC1720128 | 0.542 | 218.3 Da LogP -0.24 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@@H](CCCCC[C@@H](N)C(=O)O)C(=O)O
|
| ZINC1720130 | 0.542 | 218.3 Da LogP -0.24 TPSA 126.6 | ✓ Ro5 | ✓ Clean |
N[C@H](CCCCC[C@@H](N)C(=O)O)C(=O)O
|
| ZINC1643467 | 0.517 | 217.2 Da LogP -1.12 TPSA 117.7 | ✓ Ro5 | ✓ Clean |
CS(=O)(=O)CC[C@@H](N)P(=O)(O)O
|
| ZINC6425006 | 0.517 | 217.2 Da LogP -1.12 TPSA 117.7 | ✓ Ro5 | ✓ Clean |
CS(=O)(=O)CC[C@H](N)P(=O)(O)O
|
| ZINC34050079 | 0.516 | 224.2 Da LogP -0.91 TPSA 130.0 | ✓ Ro5 | ✓ Clean |
CS(=O)(=O)/N=C(\O)CC[C@H](N)C(=O)O
|
| ZINC1570993 | 0.500 | 215.3 Da LogP 2.93 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCC[C@H](N)C(=O)O
|
| ZINC1570999 | 0.500 | 229.4 Da LogP 3.32 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCCC[C@H](N)C(=O)O
|
| ZINC1620974 | 0.500 | 243.4 Da LogP 3.71 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCCCC[C@H](N)C(=O)O
|
| ZINC1742220 | 0.500 | 201.3 Da LogP 2.54 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCC[C@H](N)C(=O)O
|
| ZINC2035155 | 0.500 | 215.3 Da LogP 2.93 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCC[C@@H](N)C(=O)O
|
| ZINC2035157 | 0.500 | 201.3 Da LogP 2.54 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCC[C@@H](N)C(=O)O
|
| ZINC2037129 | 0.500 | 243.4 Da LogP 3.71 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCCCC[C@@H](N)C(=O)O
|
| ZINC43531622 | 0.500 | 271.4 Da LogP 4.49 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCCCCCC[C@H](N)C(=O)O
|
| ZINC43531626 | 0.500 | 271.4 Da LogP 4.49 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCCCCCC[C@@H](N)C(=O)O
|
| ZINC8437446 | 0.500 | 229.4 Da LogP 3.32 TPSA 63.3 | ✓ Ro5 | ✓ Clean |
CCCCCCCCCCC[C@@H](N)C(=O)O
|
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.